This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Achieve Pharma UK Limited. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Andrew Gareth Willis: Innovator in Pharmaceutical Chemistry
Introduction
Andrew Gareth Willis is a notable inventor based in Usk, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on cytisine salts. His research focuses on enhancing the stability and compatibility of pharmaceutical compositions.
Latest Patents
Willis holds a patent for the "Succinate salt of cytisine and use thereof." This invention relates to a novel salt of cytisine and pharmaceutical compositions that include this salt. The succinate salt of cytisine demonstrates improved excipient compatibility, which allows for the preparation of stable pharmaceutical formulations.
Career Highlights
Willis is associated with Achieve Pharma UK Limited, where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the formulation of medications that utilize cytisine, a compound known for its therapeutic potential.
Collaborations
Willis collaborates with esteemed colleagues, including Anthony Clarke and Richard Allistair Stewart. Their combined efforts contribute to the innovative research and development at Achieve Pharma UK Limited.
Conclusion
Andrew Gareth Willis is a prominent figure in pharmaceutical innovation, with a focus on improving drug formulations through his patented work. His contributions are paving the way for more effective pharmaceutical solutions.